2-(1-Ethylsulfonylazetidin-3-ylidene)acetonitrile
2-(1-Ethylsulfonylazetidin-3-ylidene)acetonitrile (CAS: 1187595-85-2) is a specialized organic intermediate primarily utilized in the synthesis of pharmaceutical active ingredients. It features an azetidine ring substituted with an ethylsulfonyl group and an exocyclic acetonitrile moiety. This specific structural configuration makes it a critical building block for modern medicinal chemistry, particularly in the development of Janus kinase (JAK) inhibitors. As a high-purity chemical intermediate, it serves as a precursor in the multi-step synthesis of various heterocyclic compounds. Its stability and reactivity are well-suited for industrial-scale organic synthesis, where precise control over molecular architecture is required. The compound is handled as a crystalline solid under standard laboratory conditions and is valued for its role in ensuring the quality and efficacy of the final therapeutic products.
• Used primarily as a key intermediate in the chemical synthesis of Baricitinib, a potent Janus kinase (JAK) inhibitor employed in the treatment of rheumatoid arthritis and other inflammatory conditions.
• Serves as a fundamental building block in medicinal chemistry research for the construction of functionalized azetidine derivatives, which are increasingly important in drug discovery programs.
• Utilized in the development of novel therapeutic agents targeting specific enzymatic pathways, providing the necessary sulfonyl-azetidine scaffold for molecular docking and interaction studies.
• Applied in industrial process chemistry to optimize the yield and purity of complex heterocyclic molecules, ensuring consistent quality in pharmaceutical manufacturing pipelines.
Product Name: 2-(1-Ethylsulfonylazetidin-3-ylidene)acetonitrile
For global customers, we provide complete technical documentation to support product evaluation, regulatory compliance and safe handling during transportation and application.